Epic Bio
Epicrispr Biotechnologies
South San Francisco, United States · Founded 2018 · $123.0M raised
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- epicrispr.com
- Total Funding
- $123.0M
- Last Round
- $68.0M Series BMar 2025
- Rounds
- 2
About
Epicrispr Biotechnologies develops therapies that dynamically control gene expression to treat complex disease by leveraging the epigenome, the ubiquitous system in mammalian cells that controls gene activity. The company describes its approach as working a level above the genome and says it can regulate any gene. Its Gene Expression Modulation System, or GEMS, is a mix-and-match platform that combines epigenomic modulators into therapies customized for specific disease indications.
Summary
Epic Bio is a Biotech company based in South San Francisco, United States, founded in 2018. It has raised $123.0M in total across 2 rounds, most recently a $68.0M Series B round in Mar 2025. Investors include Ally Bridge Group, Horizons Ventures and Solve FSHD.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2025
Sign up to see all 2 rounds
Series A through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epic-bio"><img src="https://indexed.vc/api/badge/company/epic-bio" alt="Epic Bio on Indexed.vc" width="260" height="76" /></a>